P04.25. Complementary medicine use and potential adverse reactions amongst HIV-positive people

L Braun,C Forrester,K Mackie,M Dooley,A Duncan

doi:10.1186/1472-6882-12-s1-p295

L Braun, C Forrester + Show 3 more

Open Access

https://doi.org/10.1186/1472-6882-12-s1-p295

Copy DOI

Abstract

Purpose Relatively little is known about the patterns of complementary medicine (CM) use by HIV-positive people in the last decade, since the introduction of contemporary antiretroviral therapy (ART), or their information requirements. As ART use has evolved, CM use is likely to have also changed over time, however this has yet to be established. This is of relevance to health care providers, partly because of potential risks including drug interactions, but also to understand reasons for use and intended benefits, such as managing antiretroviral therapy (ART) side effects and/or addressing existing disease symptoms. The primary aim of this study is to establish the current patterns of use of CMs by HIV-positive people in Australia. Secondary aims are to identify their main information sources and the prevalence of potential drug interactions and suspected adverse reactions to CMs.

Highlights

Relatively little is known about the patterns of complementary medicine (CM) use by HIV-positive people in the last decade, since the introduction of contemporary antiretroviral therapy (ART), or their information requirements
As ART use has evolved, CM use is likely to have changed over time, this has yet to be established
This is of relevance to health care providers, partly because of potential risks including drug interactions, and to understand reasons for use and intended benefits, such as managing antiretroviral therapy (ART) side effects and/or addressing existing disease symptoms

Summary

Introduction

Little is known about the patterns of complementary medicine (CM) use by HIV-positive people in the last decade, since the introduction of contemporary antiretroviral therapy (ART), or their information requirements. As ART use has evolved, CM use is likely to have changed over time, this has yet to be established. This is of relevance to health care providers, partly because of potential risks including drug interactions, and to understand reasons for use and intended benefits, such as managing antiretroviral therapy (ART) side effects and/or addressing existing disease symptoms. The primary aim of this study is to establish the current patterns of use of CMs by HIV-positive people in Australia.

Objectives

Results

Conclusion